UK: Dairy Crest eyes formula with Fonterra, Fayrefield Foods
Fayrefield FD John Beech, Fonterra CEO Theo Spierings and Dairy Crest CEO Mark Allen
Dairy Crest's deal with Fonterra will see the New Zealand dairy giant sell the demineralised whey powder made at the UK firm's site in Davidstow in Cornwall.
The company is also spending GBP20m at Davidstow to produce galacto-oligosaccharide, a lactose-based prebiotic used in infant formula. UK-based dairy firm Fayrefield Foods will supply an enzyme used in the ingredient and "other intellectual property". Fonterra will provide the lactose and market the prebiotic.
Commercial production of the whey powder is expected to begin "early" in Dairy Crest's 2015/16 financial year. Dairy Crest will start manufacturing the galacto-oligosaccharide later that year.
Mark Allen, Dairy Crest's chief executive, said the deals gave the owner of UK brands including Frijj milkshake and Country Life butter "exposure to global growth opportunities".
"Demineralised whey powder and GOS form an important part of Dairy Crest’s strategy to grow added value sales," he said.
- General Mills on Q1, innovation, margins
- Interview: Mondelez's outlook for China
- Aryzta FY results, outlook for 2017 - 6 takeaways
- What next for Bernard Matthews? - comment
- Interview: Mondelez eyes sweet success in China
- ConAgra acquires Frontera Foods' "gourmet" brands
- Nestle close to finalising Garoto deal
- Nestle revamps foodservice arm
- Aryzta FY profits fall
- Nestle launches Nesquik Protein Plus for adults
- The Big 15: Strategies and Priorities of Top Packaged Food Players in Comparison
- Global Chocolate Confectionery Overview: Challenges, Opportunities and Risks
- Redefining Snacks: From Conventional Snacks to Snack Replacements
- Global Foodservice Market 2016-2020
- Constellation Brands, Inc. (STZ) - Financial and Strategic SWOT Analysis Review